Letter to the Editor: Coronavirus Disease 2019 (COVID-19), Infectivity, and the Incubation Period

Beuy Joob; Viroj Wiwanitkit

doi:10.3961/jpmph.20.065

Articles

Page Path: HOME > J Prev Med Public Health > Volume 53(2); 2020 > Article

Special Section: COVID-19Correspondence Letter to the Editor: Coronavirus Disease 2019 (COVID-19), Infectivity, and the Incubation Period: Beuy Joob¹, Viroj Wiwanitkit^2,3; Journal of Preventive Medicine and Public Health 2020;53(2):70-70.
DOI: https://doi.org/10.3961/jpmph.20.065
Published online: March 31, 2020

7,012 Views
357 Download
159 Crossref
169 Scopus

¹Sanitation 1 Medical Academic Center, Bangkok, Thailand

²Department of Community Medicine, Dr DY Patil University, Pune, India

³Department of Tropical Medicine, Hainan Medical University, Haikou, China

Corresponding author: Beuy Joob, PhD Sanitation 1 Medical Academic Center, Bangkok 10150, Thailand E-mail: beuyjoob@hotmail.com

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Full Article

Download PDF

Notes
REFERENCES

See the reply "Author Response: Coronavirus Disease 2019 (COVID-19), Infectivity, and the Incubation Period" in Volume 53 on page 71.

Dear Editor,

We read with great interest the recent publication entitled “A Chinese case of coronavirus disease 2019 (COVID-19) did not show infectivity during the incubation period: based on an epidemiological survey” [1]. Bae concluded that “the epidemiological findings support the claim that the COVID-19 virus does not have infectivity during the incubation period [1].” In fact, a pathogen should not have infectivity during the incubation period or development of disease. However, the exact incubation period of COVID-19 is still unknown. In a recent report by Linton et al. [2], the incubation range was estimated as between 2 days and 14 days with 95% confidence. Exceptional cases might occur with an unusually short or long incubation period. Nevertheless, the reliability of history-taking should also be addressed. How the author was able to confirm the reliability of the patient’s self-reported history is an interesting issue for further discussion. In our country, Thailand, it is not uncommon for patients to disguise their clinical history, which can cause delays in the diagnosis of COVID-19 and exacerbate the local transmission of the disease.

Notes

CONFLICT OF INTEREST

The authors have no conflicts of interest associated with the material presented in this paper.

REFERENCES

1. Bae JM. A Chinese case of novel coronavirus 2019 (COVID-19) did not show infectivity during the incubation period: based on an epidemiological survey. J Prev Med Public Health 2020;53(2):67-69Article PubMed PMC PDF
2. Linton NM, Kobayashi T, Yang Y, Hayashi K, Akhmetzhanov AR, Jung SM, et al. Incubation period and other epidemiological characteristics of 2019 novel coronavirus infections with right truncation: a statistical analysis of publicly available case data. J Clin Med 2020;9(2):E538Article

Figure & Data

References

Citations

Citations to this article as recorded by

Acute interstitial nephritis following COVID-19 vaccination
Amnuay Kleebayoon, Viroj Wiwanitkit
Nefrología.2024; 44(2): 312. CrossRef
Correspondence on ‘COVID-19 vaccine triggered autoimmune hepatitis: case report’ by Mathewet al
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
European Journal of Hospital Pharmacy.2024; 31(1): 82.1. CrossRef
Blepharoplasty and COVID-19 Vaccination
Amnuay Kleebayoon, Viroj Wiwanitkit
Aesthetic Plastic Surgery.2024; 48(1): 55. CrossRef
In Reference to Otolaryngologic Side Effects After COVID‐19 Vaccination
Amnuay Kleebayoon, Viroj Wiwanitkit
The Laryngoscope.2024;[Epub] CrossRef
Using Immunoglobulin G Spike Antibodies as a Surrogate Marker for SARS-CoV-2 Infection: Additional Considerations
Hinpetch Daungsupawong, Viroj Wiwanitkit
Kidney Medicine.2024; 6(1): 100780. CrossRef
Comment on “SARS-CoV-2 vaccine safety and COVID-19 risk perception in hematopoietic stem cell transplant recipients”
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
Supportive Care in Cancer.2024;[Epub] CrossRef
Evaluation of T and B cell immunophenotyping and antibody response to Covid-19 vaccine: Comment
Amnuay Kleebayoon, Viroj Wiwanitkit
Indian Journal of Medical Microbiology.2024; 48: 100463. CrossRef
Re: ‘Effectiveness of a fourth SARS‐CoV‐2 vaccine dose in previously infected individuals’
Hinpetch Daungsupawong, Viroj Wiwanitkit
European Journal of Clinical Investigation.2024;[Epub] CrossRef
Adverse reactions to cosmetic implants after COVID‐19 vaccination: Correspondence
Amnuay Kleebayoon, Viroj Wiwanitkit
Journal of Cosmetic Dermatology.2024;[Epub] CrossRef
Differences in lethality and diffusion of Covid-19 and different kinds of vaccines: Correspondence
Hinpetch Daungsupawong, Viroj Wiwanitkit
Journal of Public Health Research.2024;[Epub] CrossRef
Immunogenicity of BNT162b2 vaccine after two and three doses: Correspondence
H. Daungsupawong, V. Wiwanitkit
Medicina de Familia. SEMERGEN.2024; 50(4): 102132. CrossRef
Autoimmune Optic Neuropathy and COVID-19 Vaccine
Amnuay Kleebayoon, Viroj Wiwanitkit
Journal of Neuro-Ophthalmology.2024; 44(1): e206. CrossRef
Comment on: Isolated Sixth Nerve Palsy and COVID-19
Amnuay Kleebayoon, Viroj Wiwanitkit
Journal of Neuro-Ophthalmology.2024;[Epub] CrossRef
A trade-off between lives and the economy? Subsidizing dining out under the COVID-19 pandemic in Japan
Yupeng Wang, Satoru Shimokawa
Food Policy.2024; 124: 102625. CrossRef
Cardiac inflammation associated with COVID-19 mRNA vaccination and previous myocarditis
Rujittika MUNGMUNPUNTIPANTIP, Viroj WIWANITKIT
Minerva Cardiology and Angiology.2024;[Epub] CrossRef
COVID-19-induced acute kidney injury and chronic kidney disease: comment
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
Brazilian Journal of Nephrology.2023; 45(2): 262. CrossRef
Vaccination and SARS-CoV-2 seroprevalence in blood donors: Correspondence
Pathum Sookaromdee, Viroj Wiwanitkit
Transfusion Clinique et Biologique.2023; 30(1): 22. CrossRef
Comments on “Serological response and safety of heterologous ChAdOx1-nCoV-19/mRNA-1273 prime-boost vaccination”
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
Journal of the Formosan Medical Association.2023; 122(1): 82. CrossRef
Comment on: “Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study”
Pathum Sookaromdee, Viroj Wiwanitkit
Digestive and Liver Disease.2023; 55(1): 11. CrossRef
An autopsy case report of aortic dissection after mRNA COVID-19 vaccination: correspondence
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
Legal Medicine.2023; 60: 102169. CrossRef
Lesão renal aguda induzida por COVID-19 e doença renal crônica: comentário
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
Brazilian Journal of Nephrology.2023; 45(2): 262. CrossRef
Correspondence: Clinical Course of Adverse Effects after COVID-19 Vaccination
Amnuay Kleebayoon, Viroj Wiwanitkit
Korean Journal of Family Medicine.2023; 44(5): 299. CrossRef
Long COVID-19 and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Correspondence
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
Reumatología Clínica.2023; 19(2): 119. CrossRef
COVID-19 Infection Risk, Elective Arthroplasty and Surgical Complications, and COVID-19 Vaccination: Correspondence
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
Arthroplasty Today.2023; 19: 101064. CrossRef
Response:
Dongmei Li
Allergy and Asthma Proceedings.2023; 44(1): e1a. CrossRef
Long COVID-19 and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Correspondence
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
Reumatología Clínica (English Edition).2023; 19(2): 119. CrossRef
Salivary and serum IgA and IgG after COVID-19 and after immunization with COVID-19 vaccines
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
Allergy and Asthma Proceedings.2023; 44(1): e1. CrossRef
COVID-19 vaccines and increased blood pressure
Amnuay Kleebayoon, Viroj Wiwanitkit
European Journal of Internal Medicine.2023; 112: 121. CrossRef
Cardiac magnetic resonance imaging findings in COVID-19 vaccine-related myocarditis
Rujittika Mungmunpuntipantip, Wiwanitkit Viroj
Infectious Diseases.2023; 55(4): 308. CrossRef
Re: Ipsilateral Upper-Limb Lymphedema After COVID-19 Vaccine Booster
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
Clinical Nuclear Medicine.2023; 48(9): 836. CrossRef
Heterologous mRNA-based COVID-19 booster strategies: Comment
Sora Yasri, Viroj Wiwanitkit
Human Vaccines & Immunotherapeutics.2023;[Epub] CrossRef
Comment on “COVID-19 vaccine efficacy”
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
Journal of Investigative Medicine.2023; 71(3): 307. CrossRef
Systemic lupus, immunosuppressives, COVID‐19 vaccination, and antibody response: comment on the article by Petri et al
Amnuay Kleebayoon, Viroj Wiwanitkit
Arthritis Care & Research.2023; 75(10): 2224. CrossRef
Waning of humoral immunity and COVID-19 vaccine: comment
Amnuay Kleebayoon, Viroj Wiwanitkit
Infectious Diseases.2023; 55(4): 307. CrossRef
Acute disseminated encephalomyelitis and COVID-19 vaccination: Comment
Amnuay Kleebayoon, Viroj Wiwanitkit
Journal of Clinical Neuroscience.2023; 115: 164. CrossRef
Comment on COVID‐19 vaccination during pregnancy, COVID and maternal and neonatal outcomes
Amnuay Kleebayoon, Viroj Wiwanitkit
Reviews in Medical Virology.2023;[Epub] CrossRef
Comments on: “Spectrum of Neurological Complications Following COVID-19 Vaccination in India”
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
Journal of Clinical Neurology.2023; 19(3): 322. CrossRef
SARS-CoV-2 vaccination in inflammatory bowel disease patients with different biological agents: correspondence
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
Revista Española de Enfermedades Digestivas.2023;[Epub] CrossRef
COVID-19 Vaccination in Patients Who Develop COVID-19 following Cancer Surgery: Correspondence
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
Annals of Surgical Oncology.2023; 30(4): 2108. CrossRef
COVID-19 Vaccine-Induced Immune Response in Oral Fluids and Serum: Correspondence
Pathum Sookaromdee, Viroj Wiwanitkit
International Dental Journal.2023; 73(2): 325. CrossRef
Correspondence on “COVID-19 vaccination and pregnancy”
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
Journal of Perinatal Medicine.2023; 51(7): 965. CrossRef
COVID-19 vaccines and retinal microvasculature: Comment
Amnuay Kleebayoon, Viroj Wiwanitkit
Photodiagnosis and Photodynamic Therapy.2023; 42: 103306. CrossRef
Correspondence: Neuropsychiatric post-acute sequelae of COVID-19
Amnuay Kleebayoon, Viroj Wiwanitkit
European Archives of Psychiatry and Clinical Neuroscience.2023;[Epub] CrossRef
Antibody responses to second doses of COVID-19 vaccination in lung cancer patients: comment
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
Respiratory Investigation.2023; 61(3): 332. CrossRef
Audiological and vestibular symptoms following COVID-19 and COVID-19 vaccination in children: Correspondence
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
American Journal of Otolaryngology.2023; 44(2): 103793. CrossRef
Severe coronary artery spasm after administration of a 5-hydroxytryptamine type 1 receptor agonist and SARS-CoV2 vaccination: Comment
Amnuay Kleebayoon, Viroj Wiwanitkit
Acta Cardiologica.2023; 78(8): 974. CrossRef
Correspondence on Body Weight, Anti-SARS-CoV-2 Antibody and mRNA Vaccination
Pathum Sookaromdee, Viroj Wiwanitkit
Infection & Chemotherapy.2023; 55(1): 109. CrossRef
Multiple sclerosis patients’ response to COVID-19 pandemic and vaccination: correspondence
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
The Egyptian Journal of Neurology, Psychiatry and Neurosurgery.2023;[Epub] CrossRef
Severe treatment-refractory antibody positive autoimmune autonomic ganglionopathy and COVID19 vaccination: Correspondence
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
Autoimmunity Reviews.2023; 22(2): 103233. CrossRef
Letter regarding “COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis”
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
Clinical and Molecular Hepatology.2023; 29(1): 168. CrossRef
Anti-nucleocapsid level variation to assess SARS-CoV-2 seroprevalence: comment
Amnuay Kleebayoon, Viroj Wiwanitkit
Infectious Diseases.2023; 55(6): 446. CrossRef
Letter to the Editor Regarding “The Effect of COVID-19 Vaccines on Stroke Outcomes: A Single-Center Study”
Amnuay Kleebayoon, Viroj Wiwanitkit
World Neurosurgery.2023; 171: 196. CrossRef
COVID-19 vaccine type and Guillain-Barré syndrome: Comment
Amnuay Kleebayoon, Viroj Wiwanitkit
Human Vaccines & Immunotherapeutics.2023;[Epub] CrossRef
Singing Voice Symptomatology and SARS-CoV-2 Infection: Correspondence
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
Journal of Voice.2023; 37(4): 629. CrossRef
Patients with type 2 diabetes mellitus and response to COVID-19 BNT162b2 mRNA vaccine: correspondence
Pathum Sookaromdee, Viroj Wiwanitkit
Hormones.2023; 22(1): 15. CrossRef
Sputnik V vaccine-related complications and inflammatory biomarkers: Correspondence
Pathum Sookaromdee, Viroj Wiwanitkit
Indian Journal of Medical Microbiology.2023; 44: 100357. CrossRef
Adverse effects and antibody responses following homologous and heterologous COVID19 prime-boost vaccinations
Amnuay Kleebayoon, Viroj Wiwanitkit
Journal of the Formosan Medical Association.2023; 122(5): 432. CrossRef
Placental damage in pregnant women with SARS-CoV-2 infection: Comment
Amnuay Kleebayoon, Viroj Wiwanitkit
Placenta.2023; 136: 25. CrossRef
Spike-specific humoral and cellular immune responses after COVID-19 mRNA vaccination in patients with cirrhosis
Amnuay Keebayoon, Viroj Wiwanitkit
Digestive and Liver Disease.2023; 55(3): 325. CrossRef
Comment: Baricitinib Versus Tocilizumab for the Treatment of Moderate to Severe COVID-19
Rujittika, PhD Mungmunpuntipantip, Viroj, MD Wiwanitkit
Annals of Pharmacotherapy.2023; 57(9): 1117. CrossRef
Safety and adverse events following COVID‐19 vaccination and epilepsy: Correspondence
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
Epilepsia Open.2023; 8(1): 235. CrossRef
Response to Hasdemir et al. (2023) COVID-19 vaccinations on menstrual cycle and serum anti-Mullerian hormone levels
Amnuay Kleebayoon, Viroj Wiwanitkit
Human Fertility.2023; 26(1): 186. CrossRef
CoronaVac, BNT162b2 and heterologous COVID-19 vaccine and ventricular assist device: Correspondence
Amnuay Kleebayoon, Viroj Wiwanitkit
The International Journal of Artificial Organs.2023; 46(5): 255. CrossRef
COVID‐19 infection and vaccination in pancreatobiliary IgG4‐related disease patients: Correspondence
P Sookaromdee, V Wiwanitkit
Journal of Gastroenterology and Hepatology.2023; 38(3): 476. CrossRef
Letter to the editor: COVID‐19 vaccinations in pregnancy
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
International Journal of Gynecology & Obstetrics.2023; 160(2): 719. CrossRef
COVID-19 vaccination and idiopathic sudden sensorineural hearing loss: comment
Amnuay Kleebayoon, Viroj Wiwanitkit
European Archives of Oto-Rhino-Laryngology.2023; 280(9): 4303. CrossRef
Cytokine levels in maternal and infant blood after COVID-19 vaccination during pregnancy: Correspondence
Amnuay Kleebayoon, Viroj Wiwanitkit
Journal of Reproductive Immunology.2023; 157: 103947. CrossRef
Bilateral retinal vein occlusion after COVID-19 vaccination: Correspondence
R.M. Unpuntipantip, V. Wiwanitkit
Journal Français d'Ophtalmologie.2023; 46(2): e53. CrossRef
SARS-CoV-2 infection, vaccination and acquired hemophilia: Correspondence
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
Thrombosis Research.2023; 230: 153. CrossRef
COVID‐19 vaccination and rheumatoid arthritis in older patients: Correspondence
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
Geriatrics & Gerontology International.2023; 23(1): 66. CrossRef
Development of myocarditis and pericarditis after COVID‐19 vaccination: Comment
Amnuay Kleebayoon, Viroj Wiwanitkit
Clinical Cardiology.2023; 46(4): 459. CrossRef
Correspondence on functional neurological disorders after COVID-19 and SARS-CoV-2 vaccines
Amnuay Kleebayoon, Viroj Wiwanitkit
Journal of Neurology, Neurosurgery & Psychiatry.2023; 94(9): 780. CrossRef
Central diabetes insipidus, hypophysitis and SARS-CoV-2 vaccine: Correspondence
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
Therapies.2023; 78(4): 456. CrossRef
Coronavirus disease 2019 vaccine effectiveness among a population-based cohort of people with HIV
Pathum Sookaromdee, Viroj Wiwanitkit
AIDS.2023; 37(2): 365. CrossRef
Miocarditis por lupus eritematoso sistémico y vacunación contra la COVID-19: comentario
Amnuay Kleebayoon, Viroj Wiwanitkit
Reumatología Clínica.2023; 19(6): 349. CrossRef
Response to Hasdemir et al. (2023) COVID-19 vaccinations on menstrual cycle and serum anti-Mullerian hormone levels
Amnuay Kleebayoon, Viroj Wiwanitkit
Human Fertility.2023; 26(6): 1636. CrossRef
RE: “RISK AND BENEFIT OF mRNA COVID-19 VACCINES FOR THE OMICRON VARIANT BY AGE, SEX, AND PRESENCE OF COMORBIDITY: A QUALITY-ADJUSTED LIFE YEARS ANALYSIS”
Amnuay Kleebayoon, Viroj Wiwanitkit
American Journal of Epidemiology.2023; 192(6): 1031. CrossRef
COVID-19 Vaccination Safety Profiles in Patients with Solid Tumour Cancers: Comment
A. Kleebayoon, V. Wiwanitkit
Clinical Oncology.2023; 35(7): 483. CrossRef
Competition between variants and SARS-Co-V2 epidemic, from Wuhan to XBB.1.16.: Natural selection?
Amnuay Kleebayoon, Viroj Wiwanitkit
European Journal of Internal Medicine.2023; 113: 110. CrossRef
Comment on: Kikuchi–Fujimoto disease following SARS‐CoV‐2 vaccination in a patient with previous history of rhabdomyosarcoma
Amnuay Kleebayoon, Viroj Wiwanitkit
Pediatric Blood & Cancer.2023;[Epub] CrossRef
Side effects of COVID-19 vaccination and breast cancer
Amnuay Kleebayoon, Viroj Wiwanitkit
Clinical and Experimental Medicine.2023; 23(7): 4035. CrossRef
Immunogenicity, effectiveness and safety of COVID-19 vaccine in older adults living in nursing homes: Comment
Amnuay Kleebayoon, Viroj Wiwanitkit
Revista Española de Geriatría y Gerontología.2023; 58(3): 174. CrossRef
Systemic lupus erythematosus myocarditis and COVID-19 vaccination: Comment
Amnuay Kleebayoon, Viroj Wiwanitkit
Reumatología Clínica (English Edition).2023; 19(6): 349. CrossRef
Correspondence on the evaluation of patients with COVID-19 vaccine side effects
Amnuay Kleebayoon, Viroj Wiwanitkit
Revista da Associação Médica Brasileira.2023;[Epub] CrossRef
Comment on the effectiveness of four SARS-COV-2 vaccines
Amnuay Kleebayoon, Viroj Wiwanitkit
Atención Primaria.2023; 55(7): 102655. CrossRef
Postvaccination Immunogenicity of COVID-19 Vaccine in Pediatric Inflammatory Bowel Disease: Comment
Amnuay Kleebayoon, Viroj Wiwanitkit
Journal of Pediatric Gastroenterology & Nutrition.2023; 76(6): e89. CrossRef
Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines Against COVID-19 Hospitalizations: Comment
Amnuay Kleebayoon, Viroj Wiwanitkit
Open Forum Infectious Diseases.2023;[Epub] CrossRef
Humoral response to COVID-19 vaccination and maintenance hemodialysis: Correspondence
Rujititka Mungmunpuntipantip, Viroj Wiwanitkit, Amnuay Kleebayoon
Medicina Clínica.2023; 161(7): 315. CrossRef
Inactivated (SARS-CoV-2) Vaccine, Retrobulbar Vascular Blood Flow and Retinal Vascular Density
Amnuay Kleebayoon, Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
Photodiagnosis and Photodynamic Therapy.2023; 43: 103652. CrossRef
Fulminant myocarditis following SARS-CoV-2 mRNA vaccination
Amnuay Kleebayoon, Viroj Wiwanitkit
Perfusion.2023; : 026765912311818. CrossRef
Parsonage–Turner Syndrome and COVID-19 Vaccine: Correspondence
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
Annals of Indian Academy of Neurology.2023; 26(3): 300. CrossRef
Left Ventricular Function in Patients with Myopericarditis After mRNA COVID-19 Vaccination: Comment
Amnuay Kleebayoon, Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
Pediatric Cardiology.2023; 44(7): 1632. CrossRef
SARS-CoV-2 vaccination for unexpected death from atrial myocarditis: Comment
Amnuay Kleebayoon, Viroj Wiwanitkit
Legal Medicine.2023; 64: 102283. CrossRef
Comment on immunity to COVID-19 vaccination in patients with liver disease and transplant recipients
Amnuay Kleebayoon, Viroj Wiwanitkit
Hepatology Communications.2023;[Epub] CrossRef
Side Effects Comparison of Coronavirus Vaccines Among Healthcare Workers: Comment
Amnuay Kleebayoon, Viroj Wiwanitkit
Clinical Pathology.2023;[Epub] CrossRef
Comment on: Humoral profiling of pediatric patients with cancer reveals robust immunity following anti‐SARS‐CoV‐2 vaccination superior to natural infection
Amnuay Kleebayoon, Viroj Wiwanitkit
Pediatric Blood & Cancer.2023;[Epub] CrossRef
Major cardiovascular events after COVID-19, event rates post-vaccination, antiviral or anti-inflammatory therapy, and temporal trends: Correspondence
Amnuay Kleebayoon, Viroj Wiwanitkit
Thrombosis Research.2023; 229: 40. CrossRef
Immunogenicity, safety and efficacy of COVID-19 vaccine: Correspondence
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
Indian Journal of Medical Microbiology.2023; 45: 100387. CrossRef
Generalized Eosinophilia Following Moderna COVID-19 Vaccine Administration: Comment
Amnuay Kleebayoon, Viroj Wiwanitkit
Academic Forensic Pathology.2023; 13(2): 86. CrossRef
Prior SARS-COV-2 infection, vaccination, COVID-19 hospital admission and mortality amongst nursing home residents: comment
Amnuay Kleebayoon, Viroj Wiwanitkit
Aging Clinical and Experimental Research.2023; 35(9): 1977. CrossRef
Stroke after SARS-CoV-2 vaccination: Comment
Amnuay Kleebayoon, Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
Clinics.2023; 78: 100246. CrossRef
COVID-19 and IgA Vasculitis
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
The Journal of Rheumatology.2023; 50(7): 969. CrossRef
Homologous or heterologous immunization regimens against SARS-CoV-2 after two doses of inactivated COVID-19 vaccine: Comment
Rujitika Mungmunpuntipantip, Viroj Wiwanitkit
Human Vaccines & Immunotherapeutics.2023;[Epub] CrossRef
Efficacy of COVID‐19 vaccination in adult patients with sickle cell disease: Comment
Amnuay Kleebayoon, Viroj Wiwanitkit
European Journal of Haematology.2023; 111(4): 666. CrossRef
COVID-19 Vaccine Associated with Cutaneous Involvement: Correspondence
Viroj Wiwanitkit, Rujittika Mungmunpuntipantip
Indian Journal of Critical Care Medicine.2023; 27(8): 599. CrossRef
Letter to the Editor From Kleebayoon and Wiuwanikit: “Subacute THYROiditis Related to SARS-CoV-2 VAccine and Covid-19 (THYROVAC Study): A Multicenter Nationwide Study”
Amnuay Kleebayoon, Viroj Wiwanitkit
The Journal of Clinical Endocrinology & Metabolism.2023; 109(1): e432. CrossRef
Self-reported side effects following COVID-19 vaccination in athletes: Correspondence
Pathum Sookaromdee, Viroj Wiwanitkit
Human Vaccines & Immunotherapeutics.2023;[Epub] CrossRef
SARS-CoV-2 Serological Response in Patients With Inflammatory Bowel Disease
Amnuay Kleebayoon, Viroj Wiwanitkit
Inflammatory Bowel Diseases.2023; 29(11): e44. CrossRef
COVID‐19 vaccination and myasthenia gravis
Amnuay Kleebayoon, Viroj Wiwanitkit
European Journal of Neurology.2023; 30(12): 3988. CrossRef
Humoral response to COVID-19 vaccination and maintenance hemodialysis: Correspondence
Rujititka Mungmunpuntipantip, Viroj Wiwanitkit, Amnuay Kleebayoon
Medicina Clínica (English Edition).2023; 161(7): 315. CrossRef
Axillary lymph nodes enlargement after Sars-CoV-2 vaccine in patients undergoing breast examination: comment
Amnuay Kleebayoon, Viroj Wiwanitkit
La radiologia medica.2023; 128(12): 1593. CrossRef
Livedoid skin reaction and mRNA Covid-19 vaccine: correspondence
Rujittika Mungunpuntipantip, Viroj Wiwanitkit
Pathologica.2023; 115(4): 246. CrossRef
Post-Vaccine SARS-CoV-2 Reinfection and Associated Factors Among Health Care Providers: Comment
Amnuay Kleebayoon, Viroj Wiwanitkit
Health Services Research and Managerial Epidemiology.2023;[Epub] CrossRef
Comment on “Effect of COVID vaccination on monthly migraine days”
Hinpetch Daungsupawong, Viroj Wiwanitkit
Cephalalgia.2023;[Epub] CrossRef
Humoral Response After 5 Successive Doses of COVID-19 Vaccine in Kidney Transplant Patients: Comment
Amnuay Kleebayoon, Viroj Wiwanitkit
Transplantation.2023; 107(11): e318. CrossRef
Intraneural ganglion cyst of the peroneal nerve and coronavirus disease-19 vaccination: Relationship and possible mechanism
Somsri Wiwanitkit, Viroj Wiwanitkit
Human Vaccines & Immunotherapeutics.2023;[Epub] CrossRef
Hemophagocytic lymphohistiocytosis (HLH) after COVID-19 vaccination
Somsri Wiwanitkit, Viroj Wiwanitkit
Human Vaccines & Immunotherapeutics.2023;[Epub] CrossRef
COVID-19 infection and vaccination among children
Amnuay Kleebayoon, Viroj Wiwanitkit
Clinical and Experimental Pediatrics.2023; 66(12): 531. CrossRef
Humoral response against spike protein and fifth and sixth COVID-19 mRNA vaccine in the uninfected and infected subjects: What should be for the seventh dose?
Somsri Wiwanitkit, Viroj Wiwanitkit
Human Vaccines & Immunotherapeutics.2023;[Epub] CrossRef
Comment on “Re‐infection with SARS‐CoV‐2 in solid‐organ transplant recipients”
Pathum Sookaromdee, Viroj Wiwanitkit
Transplant Infectious Disease.2022;[Epub] CrossRef
Antibody response to the messenger RNA corona virus disease 2019 vaccine in liver transplant recipients
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
Hepatology Communications.2022; 6(7): 1840. CrossRef
Re: Post-COVID-19 syndrome and humoral response association after one year in vaccinated and unvaccinated patients by Peghin et al.
Pathum Sookaromdee, Viroj Wiwanitkit
Clinical Microbiology and Infection.2022; 28(10): 1396. CrossRef
COVID-19 Vaccination and Anti-CD19 CAR T Cell-Induced B Cell Aplasia
Pathum Sookaromdee, Viroj Wiwanitkit
Transplantation and Cellular Therapy.2022; 28(8): 515. CrossRef
Correspondence on “Immunogenicity of COVID-19 Vaccine Doses in Patients With Inflammatory Bowel Disease”
Pathum Sookaromdee, Viroj Wiwanitkit
Inflammatory Bowel Diseases.2022; 28(10): e142. CrossRef
Correspondence on artificial intelligence algorithm for COVID-19 pneumonia
Pathum Sookaromdee, Viroj Wiwanitkit
Japanese Journal of Radiology.2022; 40(8): 859. CrossRef
Acute kidney injury after COVID-19 vaccines: correspondence
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
Renal Failure.2022; 44(1): 1070. CrossRef
Re: Heterologous Gam-COVID-Vac (Sputnik V)/mRNA-1273 (Moderna) vaccination
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
Clinical Microbiology and Infection.2022; 28(11): 1513. CrossRef
COVID-19 vaccination and lung transplant recipients
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
Indian Journal of Thoracic and Cardiovascular Surgery.2022; 38(S2): 354. CrossRef
Kidney Transplant Recipients With COVID-19 and Monoclonal Antibody Therapy: Additional Considerations
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
Kidney Medicine.2022; 4(8): 100502. CrossRef
Comment on D’Addio et al. Immunogenicity and Safety of SARS-CoV-2 mRNA Vaccines in a Cohort of Patients With Type 1 Diabetes. Diabetes 2022;71:1800–1806
Pathum Sookaromdee, Viroj Wiwanitkit
Diabetes.2022; 71(9): e13. CrossRef
COVID-19, vaccination and neuropsychiatric sequelae: Correspondence
Sora Yasri, Viroj Wiwanitkit
Brain, Behavior, and Immunity.2022; 106: 112. CrossRef
Comment on ”Humoral and cellular response to a third booster dose SARS-CoV- 2 vaccination in patients with autoimmune disease: a case series“
P Sookaromdee, V Wiwanitkit
Scandinavian Journal of Rheumatology.2022; 51(6): 527. CrossRef
Third dose of mRNA COVID‐19 vaccine and response: Correspondence
Pathum Sookaromdee, Viroj Wiwanitkit
Liver International.2022; 42(10): 2342. CrossRef
Kinetics of cellular and humoral responses to third COVID-19 vaccine in heart transplant recipients: Correspondence
Pathum Sokaromdee, Viroj Wiwanitkit
The Journal of Heart and Lung Transplantation.2022; 41(11): 1649. CrossRef
Antibody response to coronavirus disease 2019 vaccines after allergic reaction to first dose
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
Annals of Allergy, Asthma & Immunology.2022; 129(3): 388. CrossRef
Correspondence on Outcomes of COVID-19 in Unvaccinated Compared With Vaccinated Solid Organ Transplant Recipients
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
Transplantation.2022; 106(10): e461. CrossRef
Kinetics of cellular and humoral responses to third BNT162B2 COVID-19 vaccine over six months in heart transplant recipients - Implications for the omicron variant: Correspondence
Yael Peled, Jignseh K. Patel, Arnon Afek, Michal Mandelboim
The Journal of Heart and Lung Transplantation.2022; 41(11): 1649. CrossRef
Correspondence on ‘COVID-19 vaccine efficacy in a rapidly changing landscape’
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
Journal of Investigative Medicine.2022; 70(6): 1442. CrossRef
Comment on “Heterologous adenovirus‐vector/messenger RNA regimen, humoral response and liver transplant recipients”
Pathum Sookaromdee, Viroj Wiwanitkit
Hepatology Communications.2022; 6(12): 3598. CrossRef
Comment on “immune response to SARS-CoV-2 mRNA vaccines in patients treated with either Ibrutinib or Rituximab”
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
Clinical and Experimental Medicine.2022; 23(3): 955. CrossRef
Giant cell vasculitis post-COVID-19 mRNA vaccine and COVID-19 asymptomatic infection: Correspondence
Pathum Sookaromdee, Viroj Wiwanitkit
Vascular.2022; : 170853812211373. CrossRef
Drug induced hepatitis and SARS-CoV-2 vaccination: Correspondence
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
Clinics and Research in Hepatology and Gastroenterology.2022; 46(10): 102034. CrossRef
Efficacy and impact of SARS-CoV-2 vaccination on cancer treatment for breast cancer patients: correspondence
Rujittika Mungmunpuntipanjtip, Won Sriwijitalai, Viroj Wiwanitkit
Breast Cancer Research and Treatment.2022; 196(1): 239. CrossRef
Seroconversion after COVID‐19 vaccination and heart transplant recipients: Correspondence
Won Sriwijitalai, Viroj Wiwanitkit
Transplant Infectious Disease.2022;[Epub] CrossRef
Therapy in Patients with Hematologic Malignancies, Seroconversion Rates, and SARS-CoV-2 Vaccination
Won Sriwijitalai, Viroj Wiwanitkit
The Oncologist.2022; 27(11): e916. CrossRef
Correspondence on “Anti-SARS-Co-2 Monoclonal Antibodies and Severe Covid-19 in Kidney Transplant Patients”
Pathum Sookaromdee, Viroj Wiwanitkit
Kidney International Reports.2022; 7(10): 2319. CrossRef
Sotrovimab administration in vaccinated and unvaccinated kidney transplant recipients with SARS‐CoV‐2 infection: Correspondence
Pathum Sookaromdee, Viroj Wiwanitkit
Transplant Infectious Disease.2022;[Epub] CrossRef
Disease profile and patient outcomes in vaccinated COVID-19 patients
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
Medical Journal Armed Forces India.2022; 78(4): 497. CrossRef
Impact of COVID-19 pandemic in terms of incidence and lethality in nursing homes
Pathum Sookaromdee, Viroj Wiwanitkit
Revista Española de Geriatría y Gerontología.2022; 57(6): 337. CrossRef
SARS-CoV-2 mRNA vaccination, prostate cancer and steroids: Correspondence
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
Urologic Oncology: Seminars and Original Investigations.2022; 40(12): 541. CrossRef
Surrogate neutralization responses following SARS-CoV-2 vaccination in people with HIV
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
AIDS.2022; 36(12): 1746. CrossRef
Factors Associated With COVID-19 Breakthrough Infections: Correspondence
Rujitika Mungmunpuntipantip, Viroj Wiwanitkit
Journal of Occupational & Environmental Medicine.2022; 64(11): e793. CrossRef
Safety of mRNA BNT162b2 COVID-19 (Pfizer-BioNtech) vaccine in children aged 5-11 years: Correspondence
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
Human Vaccines & Immunotherapeutics.2022;[Epub] CrossRef
Immunity after mRNA COVID-19 vaccine and immunosuppressive therapy: correspondence
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
Acta Dermatovenerologica Alpina Pannonica et Adriatica.2022;[Epub] CrossRef
Split-dosing of coronavirus disease 2019 vaccines
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
Annals of Allergy, Asthma & Immunology.2022; 129(6): 799. CrossRef
Multiple sites of thrombosis without thrombocytopenia and COVID-19 vaccine: Correspondence
Rujittika Mungunpuntipantip, Viroj Wiwanitkit
International Journal of Immunopathology and Pharmacology.2022; 36: 039463202211489. CrossRef
COVID-19 Vaccination in Cancer Patients: Correspondence
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
Cancer Control.2022; 29: 107327482211427. CrossRef
Antibody Response to SARS-CoV-2 mRNA Vaccine Among Kidney Transplant Recipients
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
Experimental and Clinical Transplantation.2022; 20(11): 1048. CrossRef
Work within the COVID-19 pandemic — the experience of the biobank of the National Medical Research Center of Oncology
I. V. Samokhina, A. B. Sagakyants
Cardiovascular Therapy and Prevention.2020; 19(6): 2741. CrossRef

PubReader
ePub Link
Cite

CITE

export Copy Format

Close

XML Download

Related articles

Letter to the Editor: Supporting the Sick and the Vulnerable